Paula Hansen, DocuSign's Chief Revenue Officer, completed the sale of 6,000 company shares on April 1, 2026, according to a Securities and Exchange Commission filing. The disposition was carried out under a prearranged 10b5-1 trading plan and produced proceeds of $281026.
The SEC filing details that the transaction was executed in three separate blocks. Hansen sold 2,692 shares at prices ranging from $45.85 to $46.55, 3,108 shares at prices ranging from $46.87 to $47.70, and 200 shares at prices ranging from $47.90 to $48.00.
After these sales, Hansen is recorded as directly owning 79,233 shares of DocuSign. The stock was trading at $48.37 at the time of the report, a level that represents a 29% decline year-to-date and sits close to the company's 52-week low of $40.16.
Market commentary accompanying the filing included analysis from InvestingPro, which notes the stock appears undervalued at current levels and lists DocuSign among its most undervalued stocks. The platform also makes a Pro Research Report on DocuSign available, alongside reports covering more than 1,400 other U.S. equities.
Separately, DocuSign recently announced an integration with Slack that lets users create and manage contracts from within the messaging application. The integration is designed to enable teams to generate agreements, collaborate on negotiations, and complete signing workflows without leaving Slack, pulling contract data from Salesforce CRM.
Investor sentiment is mixed. Hedge fund founder Eric Jackson disclosed short positions in DocuSign as part of a broader stance across several software companies, citing research that suggests firms frequently mentioning AI on earnings calls have tended to underperform. On the sell-side, BofA Securities initiated coverage of DocuSign with an underperform rating, citing uncertainty around the company’s growth trajectory as the eSignature market matures.
Other recent analyst actions include RBC Capital lowering its price target for DocuSign to $55 from $70 while keeping a Sector Perform rating after fourth-quarter results that beat consensus but included slightly lower operating margin guidance. UBS also trimmed its price target to $54 from $75, noting concerns about the growth outlook while indicating that AI-related revenue could emerge as a potential sector catalyst.
Taken together, the insider sale, valuation commentary from InvestingPro, the Slack integration, disclosed short positions, and divergent analyst moves illustrate a company navigating product expansions and investor scrutiny as its stock trades near multiquarter lows.
Summary
- DocuSign CRO Paula Hansen sold 6,000 shares on April 1, 2026 under a 10b5-1 plan for $281026.
- Sales occurred in three tranches with price ranges from $45.85 to $48.00; Hansen now directly owns 79,233 shares.
- DocuSign shares traded at $48.37, down 29% YTD and close to a 52-week low of $40.16 amid mixed analyst views and product news.
Key points
- Insider activity: A CRO-managed 10b5-1 sale totaling 6,000 shares generated $281026, leaving Hansen with 79,233 shares.
- Market context: The stock is down 29% year-to-date and near its 52-week low of $40.16, while third-party analysis flags the stock as appearing undervalued.
- Company developments and sentiment: DocuSign announced a Slack integration for contract workflows; analysts and some investors display divergent views on growth and valuation.
Risks and uncertainties
- Growth outlook uncertainty - Analysts have flagged unclear future growth for DocuSign as the eSignature market matures, which may affect revenue trajectories and investor expectations.
- Analyst divergence and price-target cuts - Multiple firms have lowered price targets or issued underperform views, introducing potential volatility in the software and enterprise applications sector.
- Investor positioning - Public short disclosures and differing takes on AI-related upside introduce market risk to DocuSign's stock performance.